Glucagon Like Peptide 1 Agonist Market - Market Overview and Metabolic Disease Treatment
Market Overview The glucagon-like peptide 1 (GLP-1) agonist market is experiencing explosive growth as type 2 diabetes prevalence escalates, obesity epidemic expands, and GLP-1 drugs enable comprehensive metabolic disease management with cardiovascular and weight benefits beyond glucose control. The Glucagon Like Peptide 1 Agonist Market is projected to exceed USD 42.5 billion through 2030,...
0 التعليقات 0 المشاركات 62 مشاهدة 0 معاينة